$80.5 Billion is the total value of Scale Management, LLC's 5 reported holdings in Q3 2015. The portfolio turnover from Q2 2015 to Q3 2015 was 16.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| HZNP | Horizon Pharma plc | $33,901,000 | -42.9% | 1,710,451 | 0.0% | 42.13% | +8.9% | |
| HUBS | Sell | Hubspot, Inc. | $19,330,000 | -43.4% | 416,860 | -39.5% | 24.02% | +7.9% |
| EVDY | Sell | Everyday Health, Inc. | $14,570,000 | -34.0% | 1,594,085 | -7.7% | 18.11% | +25.9% |
| ALIM | Sell | Alimera Sciences, Inc. | $9,895,000 | -52.1% | 4,477,391 | -0.0% | 12.30% | -8.5% |
| OREX | Sell | Orexigen Therapeutics, Inc. | $2,770,000 | -64.1% | 1,312,575 | -15.9% | 3.44% | -31.6% |
| RNG | Exit | RingCentral, Inc. | $0 | – | -513,522 | -100.0% | -6.18% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-11-18
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Alimera Sciences, Inc. | 9 | Q4 2020 | 16.6% |
| Horizon Pharma plc | 8 | Q3 2016 | 68.2% |
| Everyday Health, Inc. | 8 | Q3 2016 | 20.4% |
| Orexigen Therapeutics, Inc. | 8 | Q3 2016 | 11.3% |
| Hubspot, Inc. | 6 | Q1 2016 | 34.3% |
| RingCentral, Inc. | 3 | Q2 2015 | 11.3% |
| JFrog Ltd. | 1 | Q4 2020 | 99.6% |
| Bill.com Holdings, Inc. | 1 | Q4 2020 | 0.1% |
View Scale Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| IPC The Hospitalist Company, Inc. | February 11, 2009 | 1,561,009 | 9.7% |
View Scale Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2021-02-12 |
| 13F-HR | 2016-11-14 |
| 13F-HR | 2016-11-14 |
| 13F-HR | 2016-05-26 |
| 13F-HR | 2016-03-02 |
| 13F-HR | 2015-11-18 |
| 13F-HR | 2015-07-29 |
| 13F-HR | 2015-06-02 |
| 13F-HR | 2015-05-19 |
| SC 13G | 2009-02-11 |
View Scale Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.